Deciphera Pharmaceuticals, Inc. Deferred Tax Assets, Other
Deciphera Pharmaceuticals, Inc. had Deferred Tax Assets, Other of $1.00 million as of 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOther · last filed 2024-02-07
- 2023-12-31: Deferred Tax Assets, Other $1.00M.
- 2022-12-31: Deferred Tax Assets, Other $893.00K.
- 2021-12-31: Deferred Tax Assets, Other $1.03M.
- 2020-12-31: Deferred Tax Assets, Other $16.00K.
| Period end | Deferred Tax Assets, Other | Deferred Tax Assets, Other as first filed |
|---|---|---|
| 2023-12-31 | $1.00M 10-K · filed 2024-02-07 | |
| 2022-12-31 | $893.00K 10-K · filed 2024-02-07 | |
| 2021-12-31 | $1.03M 10-K · filed 2023-02-07 | |
| 2020-12-31 | $16.00K 10-K · filed 2022-02-08 | |
| 2018-12-31 | -$123.00K 10-K · filed 2019-03-14 | |
| 2017-12-31 | $8.00K 10-K · filed 2019-03-14 | -$121.00K 10-K · filed 2018-03-28 |